West Pharma (WST) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $371.09 +2.57%
Revenue Growth %: +2.6%
Financial Fact:
Dividends declared per share: 0.13
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +2.6%
Financial Fact:
Dividends declared per share: 0.13
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q4 EPS of $0.54, $0.02 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $382.3 million versus the consensus estimate of $387.31 million.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Thor Industries (THO) Misses Q4 EPS by 13c
- Jefferies Starts China Oilfield Services (A-Shares) (601808:CH) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
